GLP-1 injection technique: does pinching skin actually matter?

What did @dr_jonesdc actually say?

The core claim here is straightforward: different GLP-1 pens have different injection instructions, and using the wrong technique can waste medication. Specifically, the creator says Wegovy instructs users not to pinch the skin, while Ozempic guidance depends on body composition, with leaner users potentially benefiting from a skin fold.

To be precise about the transcript: the creator says "GOVI specifically says do not pinch" and that with Ozempic, "if you're leaner, a pinch might help." The practical recommendation is to read your specific device's instructions rather than assuming one technique works across all GLP-1 pens. That's a reasonable message at its core, even if some of the specifics need scrutiny.

Does the science back this up?

The broader point, that injection technique affects subcutaneous drug delivery, is well-supported. The evidence here is not thin.

A 2016 paper by Frid et al. in Mayo Clinic Proceedings, which is one of the most comprehensive reviews on injection technique for injectable therapies, confirmed that needle length, injection site, skin fold technique, and subcutaneous fat thickness all influence drug absorption and bioavailability. The Forum for Injection Technique and Outcomes Research (FITTER) recommendations, updated in 2016, specifically address how patients with lower body fat are at higher risk of intramuscular injection when no skin fold is used, which would alter drug uptake.

For GLP-1 medications specifically, subcutaneous absorption is the intended route, and intramuscular injection can accelerate absorption in ways that may affect tolerability and efficacy. So yes, technique matters. The general claim holds up.

What did they get wrong (or right)?

Here is where it gets a little messy. The creator is largely right about the principle, but the Wegovy detail deserves a closer look.

Wegovy's prescribing information and the associated pen instructions from Novo Nordisk do not contain a universal "do not pinch" directive as a blanket rule. The guidance is more nuanced: Wegovy uses a 4mm needle, and with needles that short, a skin fold is generally not required for most adults, but it is not categorically prohibited. The FITTER consensus specifically notes that 4mm needles can be used without a skin fold in most adults, including those with lower BMI. Saying the pen "specifically says do not pinch" is an overstatement of what the labeling actually instructs.

The Ozempic body composition guidance is closer to accurate. Novo Nordisk's Ozempic instructions do account for injection depth considerations, and clinical guidance for that pen does reflect that leaner individuals may benefit from a lifted skin fold to avoid intramuscular injection. That part tracks.

The creator gets credit for flagging that device instructions differ. That is genuinely underappreciated advice.

What should you actually know?

If you are using any GLP-1 pen, the most important variables are needle length, injection site, and your own body composition. These are not interchangeable across devices.

Per the 2016 Frid et al. FITTER consensus, a 4mm pen needle is appropriate for most adults and typically does not require a skin fold regardless of BMI. Longer needles, which some older or alternative devices use, carry more risk of inadvertent intramuscular injection in leaner patients, and that is where the skin fold becomes more relevant.

Rotating injection sites also matters. Using the same spot repeatedly can cause lipohypertrophy, a localized buildup of fatty tissue, which Famulla et al. (2016, Diabetes Technology and Therapeutics) showed significantly reduces insulin and, by extension, other injectable drug absorption. The same principle applies to GLP-1 pens.

The actual actionable advice here: read the instructions that came with your specific pen, ask your prescribing provider or pharmacist if you are unsure, and do not assume that what works for one GLP-1 device applies to another. That advice is sound, even if the Wegovy detail in this video was not precisely accurate.